Mutational analysis of the estrogen receptor ligand-binding domain: Influence of ligand structure and stereochemistry on transactivation

被引:15
|
作者
Kohno, H
Bocchinfuso, WP
Gandini, O
Curtis, SW
Korach, KS
机构
[1] Lab. of Repro. and Devmtl. Toxicol., Natl. Inst. of Environ. Hlth. Sci., National Institutes of Health, Research Triangle Park, NC 27709
关键词
D O I
10.1677/jme.0.0160277
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The mouse estrogen receptor (mER) exhibits ligand stereochemical specificity for indenestrol A (IA), a stilbestrol estrogen. IA has a chiral C3 methyl group, and the mER preferentially binds the S-enantiomer (IA-S). resulting in elevated biological activity when compared with the IA-R enantiomer. To elucidate the mechanisms for this stereochemical recognition, we have constructed a series of mERs with individual amino acid substitutions at Met521, His528, Met532, and Val537. The abilities of yeast-expressed wild-type and mutant mERs to transactivate an estrogen-responsive reporter gene construct were measured in the presence of diethylstilbestrol (DES) and IA enantiomers. The concentration of IA-S required to induce half-maximal transactivation by wild-type mER was 10-fold lower than IA-R, which is attributed to the 15-fold greater binding affinity for IA-S. Wild-type mER displayed similar dose-response curves for IA-R and demethyl IA, which lacks a C3 methyl group, demonstrating that the presence and correct orientation of the C3 methyl group on the IA compound is required for high-affinity ligand binding and transcriptional activity. Each mutant exhibited a reduced preference for IA-S enantiomer with respect to transactivation, suggesting that this region of the mER functions in ligand stereochemical recognition and activation. A mutation at Met532 diminished DES- and IA-S-induced transactivation by 7.5-fold and 40-fold respectively, with minimal change on their binding affinity. These data suggest that Met532 is required for transactivation induced by the potent agonist, IA-S, and the M532G mutation effectively uncouples IA-S ligand binding from transactivation. Use of these stereochemically different ligands in combination with mutagenesis of the mER demonstrates that ligand structure could influence transactivation by specifically altering the conformation of the mER AF-2 region.
引用
收藏
页码:277 / 285
页数:9
相关论文
共 50 条
  • [1] MUTATIONAL ANALYSIS OF THE LIGAND-BINDING DOMAIN OF THE PROLACTIN RECEPTOR
    ROZAKISADCOCK, M
    KELLY, PA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (25) : 16472 - 16477
  • [2] ESTROGEN-RECEPTOR STEREOCHEMISTRY - LIGAND-BINDING AND HORMONAL RESPONSIVENESS
    KORACH, KS
    CHAE, K
    GIBSON, M
    CURTIS, S
    STEROIDS, 1991, 56 (05) : 263 - 270
  • [3] ESTROGEN-RECEPTOR STEREOCHEMISTRY - LIGAND-BINDING ORIENTATION AND INFLUENCE ON BIOLOGICAL-ACTIVITY
    CHAE, K
    GIBSON, MK
    KORACH, KS
    MOLECULAR PHARMACOLOGY, 1991, 40 (05) : 806 - 811
  • [4] MUTATIONAL ANALYSIS OF THE LIGAND-BINDING DOMAIN OF THE LOW-DENSITY LIPOPROTEIN RECEPTOR
    ESSER, V
    LIMBIRD, LE
    BROWN, MS
    GOLDSTEIN, JL
    RUSSELL, DW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1988, 263 (26) : 13282 - 13290
  • [5] Ligand-binding domain of estrogen receptors
    Mueller-Fahrnow, A
    Egner, U
    CURRENT OPINION IN BIOTECHNOLOGY, 1999, 10 (06) : 550 - 556
  • [6] Probing the structure and function of the estrogen receptor ligand binding domain by analysis of mutants with altered transactivation characteristics
    Eng, FCS
    Lee, HS
    Ferrara, J
    Willson, TM
    White, JH
    MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (08) : 4644 - 4653
  • [7] Homology model for the ligand-binding domain of the human estrogen receptor
    Maalouf, GJ
    Xu, WR
    Smith, TF
    Mohr, SC
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 1998, 15 (05): : 841 - +
  • [8] The nuclear receptor ligand-binding domain: structure and function
    Moras, D
    Gronemeyer, H
    CURRENT OPINION IN CELL BIOLOGY, 1998, 10 (03) : 384 - 391
  • [9] Structure of the homodimeric androgen receptor ligand-binding domain
    Marta Nadal
    Stefan Prekovic
    Nerea Gallastegui
    Christine Helsen
    Montserrat Abella
    Karolina Zielinska
    Marina Gay
    Marta Vilaseca
    Marta Taulès
    Adriaan B. Houtsmuller
    Martin E. van Royen
    Frank Claessens
    Pablo Fuentes-Prior
    Eva Estébanez-Perpiñá
    Nature Communications, 8
  • [10] Structure of the homodimeric androgen receptor ligand-binding domain
    Nadal, Marta
    Prekovic, Stefan
    Gallastegui, Nerea
    Helsen, Christine
    Abella, Montserrat
    Zielinska, Karolina
    Gay, Marina
    Vilaseca, Marta
    Taules, Marta
    Houtsmuller, Adriaan B.
    van Royen, Martin E.
    Claessens, Frank
    Fuentes-Prior, Pablo
    Estebanez-Perpina, Eva
    NATURE COMMUNICATIONS, 2017, 8